FDA Finalizes Guidance on Presenting Quantitative Efficacy and Risk Information in DTC Promotion | King & Spalding

On June 28, 2023, the U.S. Food and Drug Administration (“FDA”) issued final guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional...

Related Keywords

,Drug Administration ,King Spalding ,Treatment Group ,Presenting Quantitative Efficacy ,Risk Information ,Promotional Labeling ,Quantitative Information Guidance ,Risk Information From Both ,Control Group ,Quantitative Efficacy ,Drug Admin ,Direct To Consumer Promotional Labeling ,Draft Guidance ,Information Guidance ,